即时医疗(PoC)临床应用

方案

The rise of point-of-care technologies and devices has allowed for more testing and diagnosis close to the patient, resulting in increased effectiveness and success rates. Advancements in medical testing technologies (blood glucose, oxygen saturation, rapid strep, etc.) and minimally to non-invasive genomic diagnoses such as liquid biopsies have presented patients with improved point-of-care diagnostics and faster access to treatment options. Over the last several decades, onsemi has developed an extensive portfolio of intellectual property in medical applications both internally and through our partnerships with healthcare, imaging, and medical device manufacturers. Our customers rely on our product longevity that supports their long product development and regulatory approval cycles and the entire product lifecycle that can span decades. We also meet the most stringent quality requirements through our world-class manufacturing facilities, which offer ISO 13485 certification and FDA compliance.

交互式框图